These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls. Gann H; Riemann D; Stoll S; Berger M; Müller WE Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369 [TBL] [Abstract][Full Text] [Related]
26. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. Price LH; Charney DS; Heninger GR Psychopharmacology (Berl); 1986; 89(1):38-44. PubMed ID: 3016788 [TBL] [Abstract][Full Text] [Related]
27. The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients. Charney DS; Heninger GR; Sternberg DE Br J Psychiatry; 1984 Apr; 144():407-16. PubMed ID: 6326924 [TBL] [Abstract][Full Text] [Related]
28. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Charney DS; Heninger GR; Sternberg DE Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139 [TBL] [Abstract][Full Text] [Related]
29. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine. Heninger GR; Charney DS; Price LH Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050 [TBL] [Abstract][Full Text] [Related]
30. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Charney DS; Heninger GR Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014 [TBL] [Abstract][Full Text] [Related]
31. Involvement of alpha 2-adrenoceptors in the activation of kininogenesis by clonidine. Zebrowska-Lupina I; Szurska G; Klenk-Majewska B Pol J Pharmacol Pharm; 1987; 39(3):267-72. PubMed ID: 2830605 [TBL] [Abstract][Full Text] [Related]
32. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404 [TBL] [Abstract][Full Text] [Related]
33. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Nutt DJ; Glue P; Lawson C; Wilson S Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449 [TBL] [Abstract][Full Text] [Related]
34. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. Charney DS; Heninger GR; Sternberg DE; Hafstad KM; Giddings S; Landis DH Arch Gen Psychiatry; 1982 Mar; 39(3):290-4. PubMed ID: 6279050 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663 [TBL] [Abstract][Full Text] [Related]
36. Imipramine in panic disorder. 2. Effects on α2-adrenoceptor function. Nutt DJ; Glue P J Psychopharmacol; 1991 Jan; 5(2):135-41. PubMed ID: 22282365 [TBL] [Abstract][Full Text] [Related]
37. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Gurguis GN; Uhde TW Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749 [TBL] [Abstract][Full Text] [Related]